87 related articles for article (PubMed ID: 2271595)
1. Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptor.
Gerard NP; Gerard C
Biochemistry; 1990 Oct; 29(39):9274-81. PubMed ID: 2271595
[TBL] [Abstract][Full Text] [Related]
2. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells.
Boulay F; Mery L; Tardif M; Brouchon L; Vignais P
Biochemistry; 1991 Mar; 30(12):2993-9. PubMed ID: 2007135
[TBL] [Abstract][Full Text] [Related]
3. A selection system to study C5a-C5a-receptor interactions: phage display of a novel C5a anaphylatoxin, Fos-C5aAla27.
Hennecke M; Kola A; Baensch M; Wrede A; Klos A; Bautsch W; Köhl J
Gene; 1997 Jan; 184(2):263-72. PubMed ID: 9031638
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
[TBL] [Abstract][Full Text] [Related]
5. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
[TBL] [Abstract][Full Text] [Related]
7. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a receptor for C5a anaphylatoxin on human eosinophils.
Gerard NP; Hodges MK; Drazen JM; Weller PF; Gerard C
J Biol Chem; 1989 Jan; 264(3):1760-6. PubMed ID: 2912983
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5.
Evans MJ; Rollins SA; Wolff DW; Rother RP; Norin AJ; Therrien DM; Grijalva GA; Mueller JP; Nye SH; Squinto SP
Mol Immunol; 1995 Nov; 32(16):1183-95. PubMed ID: 8559143
[TBL] [Abstract][Full Text] [Related]
10. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
11. Cellular receptors to the anaphylatoxins C3a and C5a.
Huey R; Fukuoka Y; Hoeprich PD; Hugli TE
Biochem Soc Symp; 1986; 51():69-81. PubMed ID: 3545212
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic peptides against human anaphylatoxin C5a.
Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.
Perret JJ; Raspe E; Vassart G; Parmentier M
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):911-7. PubMed ID: 1472004
[TBL] [Abstract][Full Text] [Related]
14. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
15. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of C5a receptor--G-protein interactions through ligand binding.
Wennogle LP; Conder L; Winter C; Braunwalder A; Vlattas S; Kramer R; Cioffi C; Hu SI
J Cell Biochem; 1994 Jul; 55(3):380-8. PubMed ID: 7962171
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of the functional C5a receptor from human polymorphonuclear leukocytes.
Rollins TE; Siciliano S; Springer MS
J Biol Chem; 1988 Jan; 263(1):520-6. PubMed ID: 3335507
[TBL] [Abstract][Full Text] [Related]
18. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.
Ghebrehiwet B; Lim BL; Peerschke EI; Willis AC; Reid KB
J Exp Med; 1994 Jun; 179(6):1809-21. PubMed ID: 8195709
[TBL] [Abstract][Full Text] [Related]
19. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
20. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
Johnson RJ; Chenoweth DE
J Biol Chem; 1985 Aug; 260(18):10339-45. PubMed ID: 2410424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
